Arrowhead Pharmaceuticals, Inc. (ARWR)

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on December 12, 2025, th...

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-MAPT, the company...

Fisher Asset Management LLC lessened its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) by 6.5% in the undefined quarter, according to the company in its most recent 13F filing with the Secur...

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy d...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eleven brokerages that are presently covering the stock, MarketB...

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: Piper Sandler 37th Ann...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m....

Arrowhead Pharmaceuticals, Inc. ( ARWR ) TD Cowen Treatment Advancements in Obesity and Related Disorders Summit November 24, 2025 1:30 PM EST Company Participants James Hamilton - Chief Medical Offic...

The biotech published its latest set of annual results. It's now got several revenue streams that are already significantly boosting the fundamentals....

Arrowhead shares are trading higher Wednesday after the company reported better-than-expected fourth quarter financial results....